{\rtf1 \ansi 
{\colortbl;
\red0\green0\blue0;
\red255\green255\blue255;
\red255\green0\blue0;
\red0\green255\blue0;
\red0\green0\blue255;
\red0\green255\blue255;
\red255\green0\blue255;
\red255\green255\blue0;
\red0\green0\blue128;
\red0\green128\blue128;
\red0\green128\blue0;
\red128\green0\blue128;
\red128\green0\blue0;
\red128\green128\blue0;
\red128\green128\blue128;
\red192\green192\blue192;
\red170\green170\blue170;
\red85\green85\blue85;
\red255\green255\blue174;
\red183\green242\blue206;
\red37\green37\blue37;
\red33\green33\blue33;
\red255\green210\blue183;
\red119\green119\blue119;
\red238\green238\blue238;
\red20\green93\blue164;
\red246\green246\blue246;
\red14\green86\blue140;
\red255\green255\blue102;
\red80\green80\blue80;
\red51\green51\blue51;
\red56\green124\blue43;
\red204\green204\blue204;
\red151\green151\blue151;
\red0\green114\blue54;
\red112\green112\blue112;
\red106\green144\blue39;
\red21\green137\blue21;
\red255\green248\blue96;
\red247\green247\blue247;
\red239\green122\blue2;
\red107\green107\blue106;
\red232\green233\blue232;
\red249\green249\blue249;
\red249\green250\blue251;
\red228\green231\blue232;
\red254\green254\blue0;
\red181\green79\blue104;
\red233\green233\blue233;
\red203\green203\blue203;
\red127\green127\blue127;
\red245\green245\blue245;
\red71\green120\blue194;
\red190\green190\blue252;
\red255\green194\blue211;
\red187\green187\blue187;
\red242\green242\blue242;
\red240\green240\blue240;
\red105\green105\blue105;
\red204\green255\blue255;
\red236\green236\blue236;
\red61\green61\blue61;
\red188\green41\blue30;
\red190\green237\blue228;
\red229\green243\blue255;
\red179\green218\blue255;
\red120\green162\blue47;
\red251\green252\blue255;
\red72\green72\blue72;
\red190\green195\blue204;
\red208\green208\blue208;
\red227\green227\blue227;
\red255\green191\blue101;
\red149\green246\blue220;
\red223\green223\blue223;
\red239\green239\blue239;
\red255\green255\blue198;
\red118\green118\blue118;
\red172\green172\blue172;
\red9\green56\blue84;
\red212\green212\blue212;
\red102\green102\blue102;
\red240\green248\blue255;
}
{\fonttbl {
\f0 Arial;}{
\f1 Symbol;}{
\f2 Times New Roman;}{
\f3 sans-serif;}{
\f4 georgia;}{
\f5 Source Sans Pro;}{
\f6 serif;}
}
{\*\generator Apache XML Graphics RTF Library;}
\fet0 \ftnbj \paperw12240 \paperh15840 \margt1080 \margb1080 \margl1080 \margr1080 \headery720 \footery720 \itap0 \cols2 
\sectd {\header {
{\trowd \ltrrow \trleft0 
\clpadb60 \clpadfb3 \clpadl400 \clpadfl3 \clbrdrt \clbrdrb \brdrcf17 \brdrw20 \brdrs \clbrdrl \trql \clvertalb \clwWidth9380 \cellx9380 
\clpadb60 \clpadfb3 \clpadl400 \clpadfl3 \clbrdrt \clbrdrb \brdrcf17 \brdrw20 \brdrs \clbrdrr \trql \clwWidth700 \cellx10080 
\intbl 
{\b0 \cf1 \f0 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f0 \ul0 \strike0 \i0 \fs18 
}
{\b1 \cf18 \f0 \i0 \fs18 
{\b1 \cf18 \f0 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Genetic Veterinary Sciences, Inc. v. Canine EIC Genetics, LLC, 101 F.Supp.3d 833 (2015)
}
}
{\b0 \cf1 \f0 \ul0 \strike0 \i0 \fs18 
}
}\b0 \cf1 \f0 \ri0 \ul0 \strike0 \i0 \ql \fs18 \li0 \sa0 \sb0 \intbl \cell \intbl 
{\qr \b0 \cf1 \f0 \ri0 \i0 \fs18 \li0 
}\qr \b0 \cf1 \f0 \ri0 \i0 \fs18 \li0 \intbl \cell \row }
{\trowd \lastrow \trleft0 
\clbrdrb \clbrdrl \trql \clwWidth10080 \cellx10080 
\intbl 
{\b0 \cf1 \f0 \ri0 \i0 \ql \fs18 \li0 
}\b0 \cf1 \f0 \ri0 \i0 \ql \fs18 \li0 \intbl \cell \row }}\par }{\footer {
{\trowd \lastrow \trleft0 
\clpadl60 \clpadfl3 \clbrdrt \brdrcf17 \brdrw20 \brdrs \clbrdrb \clbrdrl \trql \clvertalb \clwWidth9300 \cellx9300 
\clpadl60 \clpadfl3 \clbrdrt \brdrcf17 \brdrw20 \brdrs \clbrdrb \clbrdrr \trql \clwWidth700 \cellx10000 
\intbl 
{\b0 \cf17 \f0 \ri0 \i0 \ql \fs20 \li0 
{\b0 \cf17 \f0 \ul0 \strike0 \i0 \fs20 
}
{\*\shppict {\pict \pngblip \picw78 \pich10 \picwgoal1170 \pichgoal150 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}}
{\b0 \cf17 \f0 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u169\'3f 2021 Thomson Reuters. No claim to original U.S. Government Works.
}
}\b0 \cf17 \f0 \ri0 \ul0 \strike0 \i0 \ql \fs20 \li0 \sa0 \sb0 \intbl \cell \intbl 
{\qr \b0 \cf17 \f0 \ri0 \i0 \fs20 \li0 
{\b0 \i0 \ul0 \fs20 \f0 \chpgn }
}\qr \b0 \cf17 \f0 \ri0 \ul0 \strike0 \i0 \fs20 \li0 \intbl \cell \row }}\par }
{\b0 \cf1 \f2 \ri0 \par}\sect\sbknone\pgncont\cols2{\ids0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_document_80}{\*\bkmkend co_document_80}
{\b0 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart Idb127474daab11e4a795ac035416da91_Target}{\*\bkmkend Idb127474daab11e4a795ac035416da91_Target}
\par 
}
{\b0 \qc \cf1 \f4 \ri0 \i0 \fs20 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb100 
101 F.Supp.3d 833
\par 
}
}
{\b0 \qc \cf1 \f4 \ri0 \i0 \fs20 \li0 
{\b0 \qc \cf1 \f4 \ri0 \i0 \fs20 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
United States District Court, D. Minnesota.
\par 
}
}
}
{\b0 \qc \cf21 \f4 \ri120 \i0 \fs24 \li120 
{\b0 \qc \cf21 \f4 \ri120 \i0 \fs24 \li120 
{\b0 \qc \cf21 \f4 \ri120 \i0 \fs24 \li120 
{\b0 \cf21 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
GENETIC VETERINARY SCIENCES, INC., doing business as 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Search/Results.html?query=advanced%3a+OAID(5046791887)&saveJuris=False&contentType=BUSINESS-INVESTIGATOR&startIndex=1&contextData=(sc.Default)&categoryPageUrl=Home%2fCompanyInvestigator&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem" }{\fldrslt 
{\b0 \cf28 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
Paw Print Genetics
}}}
{\b0 \cf21 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb240 
, Plaintiff,
\par 
}
}
{\b0 \qc \cf21 \f4 \ri120 \i0 \fs24 \li120 
{\b0 \cf21 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
v.
\par 
}
}
{\b0 \qc \cf21 \f4 \ri120 \i0 \fs24 \li120 
{\b0 \cf21 \f4 \ul0 \strike0 \i0 \fs24 \sa240 \sb0 
CANINE EIC GENETICS, LLC, Defendant.
\par 
}
}
}
}
{\b0 \qc \cf1 \f2 \ri0 \i0 \fs20 \li0 
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \qc \cf1 \f4 \ri0 \i0 \fs20 \li200 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Civil No. 14\u8211\'3f1598 (JRT/JJK).
\par 
}
}
}
{\b0 \cf1 \f4 \i0 \fs20 
{\b0 \qc \cf1 \f4 \ri0 \i0 \fs20 \li200 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
|
\par 
}
}
{\b0 \qc \cf1 \f4 \ri0 \i0 \fs20 \li200 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa200 \sb0 
Signed March 31, 2015.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf22 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_synopsis_80}{\*\bkmkend co_synopsis_80}
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb400 
Synopsis
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Background:
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Competitor engaged in testing dogs for exercise-induced collapse (EIC) syndrome brought action against owner of patent which identified genetic mutation for EIC syndrome and described methods for detecting whether dog had mutation, claiming patent invalidity. Case was transferred, and patent owner counter-claimed for infringement. Competitor moved for partial summary judgment on invalidity.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Holdings:
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The District Court, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0129294501&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
John R. Tunheim
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb400 
, J., held that:
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
patent was directed at patent-ineligible natural law, and
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
patent claims did not include inventive concept.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Motion granted.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b1 \cf22 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_attorneysAndLawFirms_80}{\*\bkmkend co_attorneysAndLawFirms_80}
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
Attorneys and Law Firms
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_834_80}{\*\bkmkend co_pp_sp_7903_834_80}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*834
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0320245201&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Mark P. Walters
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Lowe Graham Jones, Seattle WA, and 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0133119301&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Jonathan D. Jay
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Hellmuth & Johnson PLLC, Edina, MN, for plaintiff.
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0105191801&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Frank S. Farrell, Jr.
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0430371201&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Alexander Farrell
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
, FS Farrell, LLC, Edina, MN, for defendant.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf22 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_opinion_80}{\*\bkmkend co_opinion_80}
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269c98b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269c98b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269cb8b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269cb8b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269cb8b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269cb8b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb800 
MEMORANDUM OPINION AND ORDER GRANTING PLAINTIFF\rquote S MOTION FOR PARTIAL SUMMARY JUDGMENT
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0129294501&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
JOHN R. TUNHEIM
}}}
\sa200 
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
, District Judge.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Canine Exercise\u8211\'3fInduced Collapse causes dogs to lose control of their legs after strenuous exercise. Defendant Canine 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Genetics (\u8220\'3fCanine 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f) discovered a genetic mutation in dogs that is tied to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Canine 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 subsequently secured a patent (\u8220\'3fthe \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f) that identifies this mutation and lists eight claims, all of which describe slightly different methods for detecting whether a dog has the mutation and therefore has EIC. Plaintiff Genetic Veterinary Science, doing business as Paw Print Genetics (\u8220\'3fPPG\u8221\'3f), also tests dogs for 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Anticipating patent litigation, PPG filed this action, accusing Canine EIC of telling its customers that PPG was violating Canine EIC\rquote s patent; and claiming that the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is invalid because it protects a patent-ineligible natural law. PPG then filed a motion for partial summary judgment, seeking a declaratory judgment as to the invalidity of the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Because the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is directed at a natural law and because it does not introduce any additional inventive concept beyond well-understood, routine, and conventional methods for determining whether the EIC mutation exists in a dog, the Court will find that the patent is invalid and will grant PPG\rquote s motion for partial summary judgment.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269cc8b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269cc8b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269cc8b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269cc8b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_835_80}{\*\bkmkend co_pp_sp_7903_835_80}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*835
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb600 
BACKGROUND
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269cc8b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269cc8b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb400 
I. THE PARTIES AND THE \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 PATENT
}}}
\sb200 
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
This case involves Canine Exercise\u8211\'3fInduced Collapse (\u8220\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f), \u8220\'3fa genetic syndrome\u8221\'3f that causes dogs\u8212\'3fespecially Labrador Retrievers\u8212\'3f\u8220\'3fto lose coordination,\u8221\'3f develop \u8220\'3fa wobbly gait,\u8221\'3f and eventually lose \u8220\'3fcontrol of the[ir] hind legs.\u8221\'3f (First Am. Compl. \u182\'3f 9, Jan. 17, 2014, Docket No. 9.) Dogs who suffer from 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 usually experience these effects \u8220\'3ffive to fifteen minutes after initiation of strenuous exercise.\u8221\'3f (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
) An EIC \u8220\'3fcollapse period\u8221\'3f usually lasts five to ten minutes and the dog generally recovers fully within thirty minutes. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Canine EIC is based in St. Paul, Minnesota. (Decl. of Dr. Edward Earl Patterson in Supp. of Def.\rquote s Resp. to Pl.\rquote s Mot. for Partial Summ. J. (\u8220\'3fPatterson Decl.\u8221\'3f) \u182\'3f 2, Sept. 29, 2014, Docket No. 50.) Canine EIC co-founder Dr. Edward Earl Patterson, along with Drs. James R. Mickelson and Susan Taylor, and Katie Minor, RN, developed a genetic test to detect 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 in dogs. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f 5.) They were issued a United States patent for that development, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Patent No. 8,178,297
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, titled \u8220\'3fMethod of Detecting Canine Exercise\u8211\'3fInduced Collapse.\u8221\'3f
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.;
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Decl. of Mark P. Walters in Supp. of Mot. for Partial Summ. J. (\u8220\'3fFirst Walters Decl.\u8221\'3f), Ex. A. (\u8242\'3f297 Patent (\u8220\'3f\u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f)), Aug. 29, 2014, Docket No. 44.) The \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is dated May 15, 2012. (\u8242\'3f297 Patent.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
PPG is a Washington state company, founded in 2012 in Spokane by Dr. Lisa Shaffer. (First Am. Compl. \u182\'3f 12.) PPG has developed numerous tests for canine genetic disorders, including for EIC. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f\u182\'3f 13\u8211\'3f14.) The company has been conducting tests for 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 since August 2013. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f 18.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
According to PPG, Canine EIC has filed two lawsuits to enforce the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 297 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, both in the District of Minnesota. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f 28.) In both cases, Canine EIC \u8220\'3fcharacterized the infringing services as \u8216\'3fDNA testing services to detect whether a dog has or is predisposed to developing Canine [EIC].\u8217\'3f \u8221\'3f (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f 29.) In June 2013, principals from both PPG and Canine EIC met, and Canine EIC officials offered to license PPG\rquote s EIC testing under its patent, in exchange for a 50% royalty. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f\u182\'3f 31\u8211\'3f32.) PPG did not accept the offer and consequently concluded it was under a genuine threat of being sued by Canine EIC for patent infringement. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f 33.) Indeed, PPG alleges that Canine EIC has been informing PPG customers that PPG is not legally authorized to conduct DNA testing for canine EIC. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f\u182\'3f 
}
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf1 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8211\'3f37.) This litigation soon followed.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269cd8b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269cd8b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269cd8b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269cd8b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb400 
II. THE \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 PATENT
}}}
\sb200 
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 essentially covers assays, or tests, for determining whether a dog has, or might develop, EIC. (\u8242\'3f297 Patent, col. 1, l. 55\u8211\'3f60.) This sort of genetic testing ascertains whether the dog has mutations\u8212\'3falso called, at least at a broad level of generality, \u8220\'3falleles\u8221\'3f or \u8220\'3fpolymorphisms\u8221\'3f\u8212\'3f\u8220\'3fthat either cause a disease state or[, at a minimum,] are \u8216\'3flinked\u8217\'3f to the mutation causing a disease state.\u8221\'3f (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 6, l. 60\u8211\'3f65.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3fGenes form the basis for 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ib852f1b5475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
hereditary traits
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 in living organisms.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2111&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2111" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Ass\rquote n for Molecular Pathology v. Myriad Genetics, Inc.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (
}
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Myriad
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 ), \u8211\'3f\u8211\'3f\u8211\'3f U.S. \u8211\'3f\u8211\'3f\u8211\'3f\u8211\'3f, 133 S.Ct. 2107, 2111, 186 L.Ed.2d 124 (2013)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Genes are \u8220\'3fencoded as DNA [deoxyribonucleic acid], which takes the shape of the familiar \u8216\'3fdouble helix\u8217\'3f ... first described in 1953.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u8220\'3fEach \u8216\'3fcross-bar\u8217\'3f in the DNA helix consists of two chemically joined nucleotides. The possible nucleotides are adenine (A), thymine (T), cytosine (C), and guanine (G), each of which binds naturally with another nucleotide.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_836_80}{\*\bkmkend co_pp_sp_7903_836_80}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*836
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Polymorphism, a term used throughout the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, refers \u8220\'3fto the coexistence of more than one form of gene or portion (e.g., allelic variant) thereof. A portion of a gene of which there are at least two forms, i.e., two different nucleotide sequences, is referred to as a \u8216\'3fpolymorphic region of a gene.\u8217\'3f \u8221\'3f (\u8242\'3f297 Patent, col. 12, l. 11\u8211\'3f15.) A polymorphic region can be a single nucleotide or several nucleotides long. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 12, 1. 11\u8211\'3f19.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The term \u8220\'3fallele\u8221\'3f refers to a specific genetic sequence at a polymorphic region of a gene. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
) Alleles can have different sequence variants at different polymorphic regions. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 10, l. 33\u8211\'3f
}
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf1 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.) When multiple alleles co-exist at a genetic locus, it is called \u8220\'3fgenetic polymorphism.\u8221\'3f (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 10, l. 42\u8211\'3f44.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In developing the invention underlying the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Dr. Patterson and his colleagues first searched for the genetic source of canine EIC in order to, at a minimum, discover an allele that correlates with EIC to allow genetic testing. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 8, l. 10\u8211\'3f32.) In other words, whether or not they could discover the definitive cause of EIC, they wanted to discover a biomarker for the disease that could be identified in dogs in order to determine whether dogs have, or are susceptible to, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. They discovered a locus for the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 gene on canine chromosome 9, and further discovered four positional candidate genes in that region\u8212\'3fdynamin 1 or DNM1, PTGES2, AK1, and SLC2A8. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
) While the latter three were ruled out, \u8220\'3fa G to T nucleotide mutation at position 767 of the DNM1 gene was identified.\u8221\'3f (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
) This led to the conclusion that \u8220\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is ... caused by a point mutation at nucleic acid 767\u8221\'3f of the DNM1 gene on canine chromosome 9.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00112035751272_ID0EZIAG_80}{\*\bkmkend co_fnRef_B00112035751272_ID0EZIAG_80}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00112035751272_80" }{\fldrslt 
{\super \b0 \cf28 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
1
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 26, l. 42\u8211\'3f44; 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
see also id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 8, l. 13.) Dr. Patterson refers to this mutation as the 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Tallele
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 of the dynamin 1 gene at location 767. (Patterson Decl. \u182\'3f 6.) A dog is susceptible when it has two copies of the T allele and is consequently homozygous for \u8220\'3f767T.\u8221\'3f (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
When using the term \u8220\'3fDNM1 allele,\u8221\'3f the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 refers to both a normal allele of the DNM1 locus and an allele \u8220\'3fcarrying a variation(s) that predispose a dog to develop EIC.\u8221\'3f (\u8242\'3f297 Patent, col. 10, l. 
}
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf1 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8211\'3f45.) The latter allele is the one associated with EIC (i.e., the \u8220\'3fT allele\u8221\'3f Dr. Patterson describes in his declaration). (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Given these discoveries, the patent notes that DNA testing can now \u8220\'3fmore accurately determine if a dog with clinical signs of 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 has the heritable and \u8216\'3fclassic\u8217\'3f form of [the] disease that can be specifically attributed to this DNM1 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=I777c6a64995711de9b8c850332338889&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
gene mutation
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 9, l. 53\u8211\'3f60.) Indeed, the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 describes its invention as providing \u8220\'3fa method for detecting the presence of a biomarker associated with canine\u8221\'3f EIC. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 2, l. 49\u8211\'3f51.) The patent notes that all the test requires is a tissue sample of the dog, followed by an \u8220\'3fappropriate PCR and sequence analysis technology to detect the G to T single nucleotide change.\u8221\'3f (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 9, l. 53\u8211\'3f60.) Nevertheless, the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 includes several embodiments, describing different ways to determine whether a single nucleotide mutation at position 767 exists. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 2, l. 50\u8211\'3f65; 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 cols. 3\u8211\'3f4; 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
see also id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 22, l. 28\u8211\'3f30 (\u8220\'3fThe present invention, therefore, provides methods and kits for determining whether a subject has or is likely to develop EIC.\u8221\'3f). 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_837_80}{\*\bkmkend co_pp_sp_7903_837_80}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*837
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Specifically, the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 includes eight claims:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
1.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 A method for determining whether a dog has or is predisposed to develop Exercise Induced Collapse (
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
) comprising:
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li600 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li600 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
a) detecting in a nucleic acid sample the allele in the dynamin 1 gene at position 767 of SEQ ID NO: 1, and
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li600 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li600 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
b) identifying that the dog has or is predisposed to the development of 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 when the dog is homozygous for the T767 allele.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
2.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The method of claim 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
1,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 wherein prior to or in conjunction with detection, the nucleic acid sample is subject to an amplification step.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
3.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The method of claim 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
2,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 wherein dynamin 1 or a portion thereof is amplified.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
4.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The method of claim 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
1,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 wherein the detecting step is by a) allele specific hybridization; b) size analysis; c) sequencing; d) hybridization; e) 5\rquote  nuclease digestion; f) single-stranded conformation polymorphism; g) primer specific extension; and/or h) oligonucleotide ligation assay.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
5.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The method of claim 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
4,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 wherein the detecting step is by size analysis, and the size analysis is preceded by a restriction enzyme digestion.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
6.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The method of claim 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
1,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 wherein the detecting step is by hybridization of the nucleic acid sample from the dog to at least one oligonucleotide probe specific for the dynamin 1 (G767T) allele is immobilized on a solid surface.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
7.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The method of claim 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
1,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 wherein the dog is a Labrador Retriever, Chesapeake Bay Retriever, Curly\u8211\'3fCoated Retriever, or Border Collie.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
8.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 A method for determining whether a dog has or is predisposed to developing an Exercise Induced Collapse (
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
), comprising:
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li600 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li600 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
(a) transporting a biological sample from a dog suspected of having or being predisposed to developing 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 to a diagnostic laboratory,
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li600 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li600 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
(b) detecting in a nucleic acid sample from the dog the allele in the dynamin 1 gene at position 767 of SEQ ID NO: 1
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li600 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li600 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
(c) identifying that the dog has or is predisposed to the development of 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 when the dog is homozygous for the T767 allele and
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li600 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li600 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
(d) providing results regarding whether the dog has the EIC associated allele.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
(
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 cols. 99\u8211\'3f100.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269ce8b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269ce8b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269ce8b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269ce8b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb400 
III. THIS CASE
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Following its discussions with Canine EIC regarding the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, PPG filed suit in the Eastern District of Washington against Canine EIC. (Compl., Dec. 20, 2013, Docket No. 1.) PPG\rquote s first amended complaint, the operative complaint, seeks in Count One a declaratory judgment that all eight claims in the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 are invalid because they attempt to protect a natural law or, in the alternative, due to obviousness. (First Am. Compl. \u182\'3f\u182\'3f 45\u8211\'3f47.) In Count Two\u8212\'3fas to any claims that are not found invalid\u8212\'3fPPG seeks a declaratory judgment that PPG\rquote s test does not directly infringe on those claims. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f\u182\'3f 48\u8211\'3f49.) In the remaining three counts, PPG alleges unfair competition due to Canine EIC\rquote s statements to PPG\rquote s customers about the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, along with trade libel and tortious interference due to the same statements. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f\u182\'3f 50\u8211\'3f55.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The case was transferred from the Eastern District of Washington to the District of Minnesota on May 20, 2014. (Order re: Def.\rquote s Mot. to Dismiss for Lack of Jurisdiction or Improper Venue, May 20, 2014, Docket No. 28.) On June 3, 2014, Canine EIC filed its answer and also counterclaimed 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_838_80}{\*\bkmkend co_pp_sp_7903_838_80}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*838
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 that PPG had infringed on the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. (Canine EIC\rquote s Answer & Countercl. to Pl.\rquote s First Am. Compl., June 3, 2014, Docket No. 36.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
PPG filed a motion for partial summary judgment on August 29, 2014. (Pl.\rquote s Mot. for Partial Summ. J., Aug. 29, 2014, Docket No. 42.) The motion seeks summary judgment on Counts One and Two of PPG\rquote s complaint. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
) Specifically, PPG seeks a declaratory judgment that the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is invalid because it protects a natural law. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269cf8b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269cf8b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269cf8b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269cf8b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb600 
ANALYSIS
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269cf8b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269cf8b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb400 
I. STANDARD OF REVIEW
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf28 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B12035751272_80}{\*\bkmkend co_anchor_B12035751272_80}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Summary judgment is appropriate where there are no genuine issues of material fact and the moving party can demonstrate that it is entitled to judgment as a matter of law. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR56&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RB&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_8b3b0000958a4" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Fed.R.Civ.P. 56(a)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. A fact is material if it might affect the outcome of the suit, and a dispute is genuine if the evidence is such that it could lead a reasonable jury to return a verdict for either party. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1986132674&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Anderson v. Liberty Lobby, Inc.,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 477 U.S. 242, 248, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. A court considering a motion for summary judgment must view the facts in the light most favorable to the non-moving party and give that party the benefit of all reasonable inferences to be drawn from those facts. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1986115992&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Matsushita Elec. Indus. Co. v. Zenith Radio Corp.,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 475 U.S. 574, 587, 106 S.Ct. 1348, 89 L.Ed.2d 538 (1986)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Federal courts have the authority to grant summary judgment on the issue of patent invalidity when the subject of the patent is ineligible for patent protection. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027201140&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_1323&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1323" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Fort Props., Inc. v. Am. Master Lease LLC,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 671 F.3d 1317, 1323\u8211\'3f24 (Fed.Cir.2012)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (affirming the district court\rquote s decision to grant summary judgment to the plaintiffs because the patent in question \u8220\'3fattempt[ed] to capture unpatentable abstract subject matter\u8221\'3f).
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269d08b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269d08b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269d08b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269d08b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb400 
II. RELEVANT CASE LAW
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section
}
}
{\b0 \cf1 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf1 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 of the Patent Act governs patent eligibility, stating \u8220\'3f[w]hoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title.\u8221\'3f
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Given the language of the claims in the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8212\'3feach one describes a \u8220\'3fmethod\u8221\'3f\u8212\'3fthis case clearly involves claims of new and useful 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
processes
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, which are also known as \u8220\'3fmethod claims.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2025880702&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_1374&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1374" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
CyberSource Corp. v. Retail Decisions, Inc.,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 654 F.3d 1366, 1374\u8211\'3f75 (Fed.Cir.2011)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The Supreme Court has long recognized an exception to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, however: \u8220\'3f[L]aws of nature, natural phenomena, and abstract ideas are not patentable.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_1293&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1293" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo Collaborative Servs. v. Prometheus Labs.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (
}
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 ), \u8211\'3f\u8211\'3f\u8211\'3fU.S. \u8211\'3f\u8211\'3f\u8211\'3f\u8211\'3f, 132 S.Ct. 1289, 1293, 182 L.Ed.2d 321 (2012)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (internal quotation marks omitted). These exceptions are meant to avoid \u8220\'3ftying up the future use of the[ ] building blocks of human ingenuity.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2355&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2355" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Alice Corp. Pty. Ltd. v. CLS Bank Int\rquote l
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (
}
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Alice Corp.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
), \u8211\'3f\u8211\'3f\u8211\'3f U.S. \u8211\'3f\u8211\'3f\u8211\'3f\u8211\'3f, 134 S.Ct. 2347, 2355, 189 L.Ed.2d 296 (2014)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (internal quotation marks omitted). At the same time, the Supreme Court has cautioned against construing these exceptions so broadly that they \u8220\'3fswallow all of patent law.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 the Supreme Court established a two-step process for distinguishing between those cases that fall within, and those that lie outside, the list of exceptions. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2355&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2355" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2355
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The first step
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is to determine \u8220\'3fwhether the claims at issue are directed to one of those patent-ineligible concepts\u8221\'3f (i.e., law of nature, natural phenomena, abstract idea). 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 In answering that question, courts look to the elements of each claim both individually and in \u8220\'3f \u8216\'3fan 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_839_80}{\*\bkmkend co_pp_sp_7903_839_80}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*839
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 ordered combination\u8217\'3f to determine whether the additional elements \u8216\'3ftransform the nature of the claim\u8217\'3f into a patent-eligible application.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_1297&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1297" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 132 S.Ct. at 1297\u8211\'3f98
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
). Assuming that the claims are directed at a patent-ineligible concept, 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
step two
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is \u8220\'3fa search for an inventive concept\u8212\'3fi.e., an element or combination of elements that is sufficient to ensure that the patent in practice amounts to significantly more than a patent upon the [ineligible concept] itself.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (internal quotation marks omitted).
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269d18b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269d18b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269d18b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269d18b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
A. 
}
{\b1 \cf1 \f2 \i1 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb400 
Mayo
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Before delving into the 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 test as it applies to this case, the Court will review Supreme Court and lower court case law applying and interpreting the 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 principles. The 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 case itself involved a summary judgment dispute over \u8220\'3fpatent claims covering processes that help doctors who use thiopurine drugs to treat patients with 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ic39e7bac475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
autoimmune diseases
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 determine whether a given dosage level is too low or too high.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_1294&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1294" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 132 S.Ct. at 1294, 1296
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The patents involved research that used the concentrations of metabolites in a patient\rquote s blood to determine whether the patient was receiving too much or too little thiopurine. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_1295&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1295" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1295
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The patent claims covered a simple set of processes, whereby the drug was administered, the level of certain metabolites in the blood stream was measured, and the amount of the drug being administered was either increased or decreased. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The Court concluded that the patents set forth laws of nature: \u8220\'3fnamely, relationships between concentrations of certain metabolites in the blood and the likelihood that a dosage of a thiopurine drug will prove ineffective or cause harm.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_1296&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1296" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1296
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. That relationship alone is a natural law and, as a result, patent-ineligible. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_1297&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1297" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1297
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The key question of the case, then, was \u8220\'3fwhether the [patent] claims do significantly more than simply describe these natural relations.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The claims needed to \u8220\'3fadd 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
enough
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 to their statements of the correlations to allow the processes they describe to qualify as patent-eligible processes that 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
apply
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 natural laws.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In analyzing the steps in the process envisioned by the patent, individually and in the aggregate, the Court concluded that the claims did not add enough to garner patent protection. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The administering step in the process merely referred to the relevant audience of doctors administering thiopurine, which offered little beyond the natural law since doctors had been administering that drug long before the patent was issued. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Moreover, as the Court noted, inventors cannot get around the bar on patenting natural laws or abstract ideas by \u8220\'3flimit[ing] the use of the formula to a particular technological environment.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (internal quotation marks omitted). The \u8220\'3fwherein\u8221\'3f clause of the process simply listed the relevant natural laws. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 And the determining step, which states the triggering metabolite levels in the blood, simply told doctors to test for metabolite levels using well-established monitoring methods\u8212\'3fnothing significant enough to result in patent protection. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_1298&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1298" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1298
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Additionally, considering the steps in the aggregate did not change the Court\rquote s analysis. The Court concluded that the patent \u8220\'3fclaims inform a relevant audience about certain laws of nature; any additional steps consist of well-understood, routine, conventional activity already engaged in by the scientific community; and those steps, when viewed as a whole, add nothing significant beyond the sum of their parts taken separately.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The Court consequently held that the patent claims at issue were invalid. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_1305&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1305" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1305
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269d28b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269d28b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269d28b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269d28b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
B. 
}
{\b1 \cf1 \f2 \i1 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb400 
Myriad
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The following year, the Court decided another patent-eligibility summary judgment 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_840_80}{\*\bkmkend co_pp_sp_7903_840_80}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*840
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 dispute in 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Myriad.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 That case did not require the application of both 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 steps, since the patent at issue was a composition claim, and not a process or method claim. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2116&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2116" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Myriad,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 133 S.Ct. at 2116
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Neither patent 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
applied
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 the patented concept, as might be more common in a process or method claim, in a way that would trigger the two-step 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 analysis. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2112&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2112" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2112\u8211\'3f13, 2120
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f[T]his case does not involve patents on new 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
applications
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 of knowledge about the BRCA1 and BRCA2 genes.\u8221\'3f (emphasis added)). Nevertheless, the case is relevant because it discusses patents related to genetic testing and biomarker detection.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The inventions at issue involved the BRCA1 and BRCA2 genes. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2112&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2112" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2112
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=I777c6a64995711de9b8c850332338889&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Mutations in those genes
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u8220\'3fcan dramatically increase an individual\rquote s risk of developing breast and ovarian 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Iaf34f5c3475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
cancer
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Defendant patent-holder Myriad had patented two \u8220\'3finventions\u8221\'3f: (1) the identification, isolation, and extraction of the BRCA genes; and (2) the creation of a synthetic form of those genes. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2112&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2112" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2112\u8211\'3f13
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The patents, if valid, would have given Myriad the exclusive right to isolate an individual\rquote s BRCA genes and, effectively, the exclusive right to test for BRCA. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See 
}
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2113&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2113" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2113\u8211\'3f14
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f[I]solation is necessary to conduct genetic testing.\u8221\'3f) The Court considered challenges to some, but not all, of the patents Myriad obtained. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2113&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2113" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2113
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
As to the first invention, the Court noted that Myriad \u8220\'3fdid not create or alter any of the genetic information encoded in the BRCA1 and BRCA2 genes.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2116&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2116" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2116
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Indeed, the \u8220\'3flocation and order of the nucleotides existed in nature before Myriad found them.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Moreover, Myriad also did not \u8220\'3fcreate or alter the genetic structure of [the] DNA.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The Court characterized Myriad\rquote s principal contribution as \u8220\'3funcovering the precise location and genetic sequence of the BRCA1 and BRCA2 genes within chromosomes 17 and 13.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The Court noted that while the company had found a very important gene, discovering it and separating it from its surrounding genetic material \u8220\'3fis not an act of invention.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2117&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2117" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2117
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. As a result, the first invention did not merit patent protection. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Creating the synthetic gene (called \u8220\'3fcDNA\u8221\'3f), something entirely new, on the other hand, did qualify for patent protection. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2119&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2119" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2119
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In its concluding paragraphs, the Court noted that while Myriad might have also sought to bring a method or process claim\u8212\'3fwhich would more likely trigger the 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 two-step analysis\u8212\'3fsuch a claim might fail as well. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The Court noted that \u8220\'3fthe processes used by Myriad to isolate DNA were well understood by geneticists at the time of Myriad\rquote s patents.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 They were \u8220\'3fwell understood, widely used, and fairly uniform insofar as any scientist engaged in the search for a gene would likely have utilized a similar approach.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2119\u8211\'3f20 (internal quotation marks omitted).
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269d38b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269d38b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269d38b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269d38b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
C. 
}
{\b1 \cf1 \f2 \i1 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb400 
Alice Corp.
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The Supreme Court next decided 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Alice Corp.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 That case involved the \u8220\'3fabstract idea\u8221\'3f exception, and not a natural law exception.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00222035751272_ID0EY6BG_80}{\*\bkmkend co_fnRef_B00222035751272_ID0EY6BG_80}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00222035751272_80" }{\fldrslt 
{\super \b0 \cf28 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
2
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The claims at issue covered a computerized scheme that mitigated \u8220\'3fsettlement risk\u8221\'3f between contracting parties. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2352&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2352" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Alice Corp.,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 134 S.Ct. at 2352
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. At 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 step one, the Court concluded that the patent\rquote s claims revolved around an abstract idea\u8212\'3fthe concept of intermediated settlement (i.e., using a third party to reduce 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_841_80}{\*\bkmkend co_pp_sp_7903_841_80}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*841
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 settlement risk). 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2356&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2356" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2356
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. That concept is \u8220\'3fa fundamental economic practice long prevalent in our system of commerce.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (internal quotation marks omitted).
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The Court proceeded to 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 step two, looking for some inventive concept beyond the abstract idea. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2357&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2357" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2357
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The Court noted that this step requires more than an abstract idea, with the words \u8220\'3fapply it\u8221\'3f added on. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2358&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2358" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2358
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Here, the additional element beyond the abstract idea was the computer program which applied that abstract idea. But the Court noted that \u8220\'3fwholly generic computer implementation is not generally the sort of additional feature that provides any practical assurance that the process is more than a drafting effort designed to monopolize the [abstract idea] itself.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (internal quotation marks omitted). Analyzing the steps covered by the patent, the Court concluded that the computer application involved nothing more than \u8220\'3fwell-understood, routine, conventional activities previously known to the industry.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2359&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2359" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2359
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (internal quotation marks and alterations omitted). And the Court reached the same conclusion when it analyzed the patent\rquote s steps as an ordered combination. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3fViewed as a whole, petitioner\rquote s method claims simply recite the concept of intermediated settlement as performed by a generic computer.\u8221\'3f). Thus, under 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 the patent was invalid because it covered an abstract idea. The Court affirmed the Federal Circuit, which had affirmed the district court\rquote s grant of summary judgment, concluding that the subject matter of the patent was ineligible under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2353&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2353" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2353, 2360
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269d48b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269d48b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269d48b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269d48b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
D. 
}
{\b1 \cf1 \f2 \i1 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb400 
BRCA
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
In re BRCA1\u8211\'3f and BRCA2\u8211\'3fBased Hereditary Cancer Test Patent Litigation
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (
}
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
BRCA
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 ), 774 F.3d 755 (Fed.Cir.2014)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the Federal Circuit considered an appeal of a denial of a preliminary injunction, which arose from additional litigation related to the BRCA patents at issue in the Supreme Court\rquote s 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Myriad
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 decision. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_758&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_758" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 758
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Relevant here, the court considered challenges to two claims of the BRCA patents that involved patented methods. Specifically, \u8220\'3f[t]he methods, directed to identification of alternations of the gene, require [d] merely comparing the patient\rquote s gene with [a wild-type gene] and identifying any differences that arise.\u8221\'3f
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_763&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_763" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 763
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
One party argued these methods claims were ineligible under 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 because they \u8220\'3fsimply identify a law of nature (the precise sequence of the BRCA genes, and comparisons of the wild-type BRCA sequences with certain mutations of those gene sequences found in the test subject) and apply conventional techniques.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_762&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_762" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 762
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The court opted not to decide whether 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 was directly on point, however, because the method claims at issue \u8220\'3fsuffer[ed] from a separate infirmity: they recite abstract ideas.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_762&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_762" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 762\u8211\'3f63
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3fLaws of nature are not the only implicit exception to patentable subject matter by 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Natural phenomena and abstract ideas are also not patentable.\u8221\'3f). The comparison of wild-type BRCA sequences with mutations of those sequences was an abstract idea that the court found corresponded with 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 step one. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_763&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_763" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 763\u8211\'3f64
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
After concluding the two claims were directed at a patent-ineligible concept\u8212\'3fan abstract idea, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_764&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_764" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 764
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8212\'3fthe court moved on to 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 step two, asking \u8220\'3fwhether the remaining elements, either in isolation or combination with the other non-patent-ineligible elements, are sufficient to transform the nature of the claim into a patent-eligible application.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_763&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_763" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 763
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (internal quotation marks omitted). For that step, the court looked to the remainder of the patent claims, specifically \u8220\'3fthe techniques to be used in making the comparisons\u8221\'3f between the wild-type sequences and mutations. 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_842_80}{\*\bkmkend co_pp_sp_7903_842_80}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*842
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The court then concluded that the claims did not \u8220\'3fadd enough to make\u8221\'3f themselves patent eligible. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_764&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_764" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 764
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Indeed, the patent holder, Myriad, did \u8220\'3fnot challenge the ... finding that the claims contain no otherwise new process for designing or using probes, primers, or arrays beyond the use of BRCA1 and BRCA2 sequences in those processes.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (internal quotation marks omitted). The court concluded that the claims did \u8220\'3fnothing more than spell out what practitioners already knew\u8212\'3fhow to compare gene sequences using routine, ordinary techniques.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Indeed, these were exactly the \u8220\'3fwell-understood, routine, and conventional techniques that a scientist would have thought of when instructed to compare two gene sequences.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The court compared the patents at issue to a different BRCA patent from a related case (\u8220\'3fclaim 21 of the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1998348225&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=Ibce1a8d0722911d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
441 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f or \u8220\'3fclaim 21\u8221\'3f), which a Federal Circuit judge had suggested was patent eligible. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 764\u8211\'3f65. That patent also involved a comparison between wild-type BRCA genes and mutations in a patient\rquote s genes. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Assuming, without deciding, that claim 21 was patent eligible, the court noted that that patent was different than the patents at issue. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Claim 21 was more limited and narrow. It was \u8220\'3flimited to the particular mutations the inventors discovered: detecting ten specific mutations from the wild-type, identified as predisposing mutations, for the specific purpose of identifying increased susceptibility to specific 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Iaf34f5c3475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
cancers
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 765 (internal quotation marks and alterations omitted). The court noted that the claims it was reviewing were \u8220\'3fsignificantly broader and more abstract, as they claim[ed] all comparisons between the patient\rquote s BRCA genes and the wild-type BRCA genes.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The court ultimately affirmed the district court\rquote s denial of the preliminary injunction to Myriad, holding that all \u8220\'3fclaims on appeal are directed to ineligible subject matter in violation of 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269d58b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269d58b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269d58b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269d58b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
III. 
}
{\b1 \cf1 \f2 \i1 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
MAYO
}
}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb400 
 STEP ONE: DIRECTED AT PATENT\u8211\'3fINELIGIBLE CONCEPT
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf28 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B22035751272_80}{\*\bkmkend co_anchor_B22035751272_80}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The first step is to \u8220\'3fdetermine whether the claims at issue are directed to a patent-ineligible concept.\u8221\'3f
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2355&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2355" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Alice Corp.,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 134 S.Ct. at 2355
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. At the hearing, Canine EIC clarified that it believes its patent is 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
not
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 directed toward a natural law. Canine EIC compares this case with 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
BRCA.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Noting that that case involved broad and abstract patents, which \u8220\'3fclaim[ed] all comparisons between the patient\rquote s 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_765&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_765" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
BRCA genes and the wild-type BRCA genes,\u8221\'3f 
}
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
BRCA,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 774 F.3d at 765
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Canine EIC argues that its patent claims are much more narrowly drawn, patenting only one test that identifies one mutation that is tied to one disease.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf28 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B32035751272_80}{\*\bkmkend co_anchor_B32035751272_80}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Although this argument may be relevant to the inquiry at 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 step two, it does not alter the Court\rquote s step one analysis. Whether a claim is narrowly drawn, or more broadly attempts to capture every facet of a law of nature, is a debate that is relevant at 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 step two, when a court determines to what extent a patent that is directed toward a patent-ineligible subject features a patentable inventive concept. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See, e.g., 
}
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_1301&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1301" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 132 S.Ct. at 1301\u8211\'3f02
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (analyzing the breadth and abstractness of a patent in the second stage of the 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 analysis); 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2034293397&pubNum=0000999&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Genetic Techs. Ltd. v. Lab. Corp. of Am. Holdings,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 No. 12\u8211\'3f1736, 2014 WL 4379587, at *14 (D.Del. Sept. 3, 2014)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (same).
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf28 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B42035751272_80}{\*\bkmkend co_anchor_B42035751272_80}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Here, the Court concludes that the \u8242\'3f279 Patent is directed at a patent-ineligible natural law.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00332035751272_ID0EF4AI_80}{\*\bkmkend co_fnRef_B00332035751272_ID0EF4AI_80}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00332035751272_80" }{\fldrslt 
{\super \b0 \cf28 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
3
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Each of the of patent\rquote s 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_843_80}{\*\bkmkend co_pp_sp_7903_843_80}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*843
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 claims serves the overarching purpose of \u8220\'3fdetermining whether a dog has or is susceptible to developing\u8221\'3f EIC. (\u8242\'3f297 Patent, col. 1, l. 57\u8211\'3f59.) The patent\rquote s methods reach that EIC determination by identifying the naturally occurring source of 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8212\'3fa \u8220\'3fpoint mutation at nucleic acid 767\u8221\'3f\u8212\'3fand testing dogs for that mutation. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 26, l. 40\u8211\'3f45; 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
see also id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 2, l. 49\u8211\'3f51 (\u8220\'3fThe present invention provides a method for detecting the presence of a biomarker associated with canine [EIC].\u8221\'3f).) Indeed, the only two independent claims (i.e., that do not merely modify and refer back to a prior claim) are claims one and eight, and both of them state as their central purpose the discovery of whether an individual dog\rquote s genetic code displays evidence of a mutation that correlates with EIC. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 99, l. 24\u8211\'3f26 (\u8220\'3fA method for determining whether a dog has or is predisposed to develop [EIC].\u8221\'3f); 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 100, l. 30\u8211\'3f33 (same).) The \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote s claims, just like those in 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Myriad,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 for example, are directed at identifying and observing a natural law\u8212\'3fa genetic mutation that is tied to a disease in a living organism. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2116&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2116" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Myriad,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 133 S.Ct. at 2116\u8211\'3f19
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (discussing the identification and isolation of genes that, when they experience mutations, can lead to a higher risk of breast and ovarian 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Iaf34f5c3475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
cancer
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
).
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Even if, as Canine EIC argues, some of the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 claims involve non-natural processes or materials, those claims are still directed at identifying a genetic biomarker that exists in nature. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See 
}
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_1297&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1297" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 132 S.Ct. at 1297
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3fWhile it takes human action ... to trigger a manifestation of this relation in a particular person, the relation itself exists in principle apart from any human action.\u8221\'3f); 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2034293397&pubNum=0000999&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Genetic Techs. Ltd.,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 2014 WL 4379587, at *10
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (recommending that the district court grant the defendants\rquote  motion to dismiss due to patent ineligibility, and concluding, at 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 step one, that a patent that \u8220\'3fsets out the correlation between a particular genetic variation and sprinting, strength or power performance,\u8221\'3f is directed at \u8220\'3fa natural process, [and is] an eternal truth that exists in principle apart from any human action\u8221\'3f (internal quotation marks omitted)). Unlike the cDNA patent in 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Myriad,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 the patent claims at issue here are not directed at creating entirely new, non-natural genetic material.
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2119&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2119" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Myriad,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 133 S.Ct. at 2119
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Instead, the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 uses non-natural processes to serve its purpose of identifying a natural law. Consequently, the Court concludes that the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is directed at natural law, and moves next to 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 step two.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00442035751272_ID0E4JBI_80}{\*\bkmkend co_fnRef_B00442035751272_ID0E4JBI_80}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00442035751272_80" }{\fldrslt 
{\super \b0 \cf28 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
4
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269d68b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269d68b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269d68b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269d68b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
IV. 
}
{\b1 \cf1 \f2 \i1 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
MAYO
}
}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb400 
 STEP TWO: INVENTIVE CONCEPT
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf28 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B52035751272_80}{\*\bkmkend co_anchor_B52035751272_80}
}
{\b0 \cf28 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B62035751272_80}{\*\bkmkend co_anchor_B62035751272_80}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 At 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 step two, the Court \u8220\'3fmust examine the elements of the claim[s 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_844_80}{\*\bkmkend co_pp_sp_7903_844_80}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*844
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at issue] to determine whether [they] contain[ ] an inventive concept sufficient to transform the claimed\u8221\'3f natural law \u8220\'3finto a patent-eligible application.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2357&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2357" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Alice Corp.,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 134 S.Ct. at 2357
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The Court asks whether the claims \u8220\'3fadd enough to their statements of the [correlation between certain mutations and Canine EIC] to allow the processes they describe to qualify as patent-eligible processes that apply natural laws.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_1297&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1297" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 132 S.Ct. at 1297
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The steps in the patent, beyond the law of nature, must be more than \u8220\'3fwell-understood, routine, conventional activity already engaged in by the scientific community.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_1298&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1298" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1298
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf28 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B72035751272_80}{\*\bkmkend co_anchor_B72035751272_80}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 In light of these principles, the Court concludes that none of the eight claims of the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 includes any inventive concept. Outside of the natural law relationship between the T767 allele and EIC, the techniques or methods identified in the claims, whether viewed individually or in the aggregate, were at the time the patent was issued \u8220\'3fwell-understood, routine, and conventional techniques that a scientist would have thought of when instructed to\u8221\'3f test whether a certain allele exists at a specific genetic location. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_764&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_764" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
BRCA,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 774 F.3d at 764
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Indeed, that is why the Patent Examiner, in examining what distinguished the subject of this patent from the prior art in the field, focused only on the natural law. (First Walters Decl., Ex. B at 4\u8211\'3f5 (\u8220\'3fThe prior art fails to provide the link between dynamin\u8211\'3f1 and EIC.\u8221\'3f).) The examiner did not highlight anything unique about the methods and processes used in the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 to identify the \u8220\'3flink between dynamin\u8211\'3f1 and EIC.\u8221\'3f (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
An analysis of the various claims at issue supports this conclusion. Claim one simply states the natural law at the heart of the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (i.e., the biomarker\u8212\'3fthe T767 allele\u8212\'3fthat is tied to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
), and then describes detecting that biomarker through \u8220\'3fa nucleic acid sample\u8221\'3f and, if that nucleic acid sample shows that the dog is homozygous for the T767 allele, then identifying the dog as having or being predisposed to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. (\u8242\'3f297 Patent, col. 99, l. 24\u8211\'3f32.) Simply detecting a patent-ineligible concept\u8212\'3fin this case a natural law\u8212\'3fand then identifying the law once it is detected, is not enough to render the subject matter patentable. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See, e.g., 
}
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2031885892&pubNum=0007903&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_7903_949&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_7903_949" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Ariosa Diagnostics, Inc. v. Sequenom, Inc.,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 19 F.Supp.3d 938, 949\u8211\'3f50 (N.D.Cal.2013)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (noting that the methods used to detect DNA sequences under the patent claims at issue were \u8220\'3fwell-understood, routine, and conventional\u8221\'3f); 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2034293397&pubNum=0000999&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Genetic Techs. Ltd.,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 2014 WL 4379587, at *12
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f[T]he [patent\rquote s] \u8216\'3fdetecting\u8217\'3f step fares no better [under the 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 step two analysis]. It simply tells users of the process to detect the presence of two 577R alleles in the sample, again without specifying any particular method for doing so.\u8221\'3f).
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Claims two and three offer nothing more, beyond routine and conventional processes. Both reference claim one, and both use an amplification process: claim two involves the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=mproc&entityId=Iaeee0129475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
amplification of the nucleic acid
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 sample and claim three involves the dynamin 1 gene being amplified. (\u8242\'3f297 Patent, col. 99, l. 33\u8211\'3f37.) Amplification is also a routine, well-known, and conventional step for detecting a biomarker.
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The court in 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Ariosa Diagnostics, Inc.,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 for example, concluded that a patent that used amplification as a method to detect cell-free fetal DNA (\u8220\'3fcffDNA\u8221\'3f) in serum or plasma samples from a pregnant female, did not feature an inventive concept that was sufficient to warrant patent eligibility. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2031885892&pubNum=0007903&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_7903_941&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_7903_941" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
19 F.Supp.3d at 941\u8211\'3f42, 948\u8211\'3f49
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (citing expert testimony that \u8220\'3fthe amplification and detection of DNA sequences in plasma or serum was well known by 1997\u8221\'3f). Indeed, as PPG points out, even the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 itself labels amplification as a well-known and widely used technique for genetic detection. 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_845_80}{\*\bkmkend co_pp_sp_7903_845_80}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*845
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, col. 4, l. 7\u8211\'3f13 (\u8220\'3f \u8216\'3fAmplifying\u8217\'3f utilizes methods such as the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=mproc&entityId=Ic0f729ad475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
polymerase chain reaction
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (PCR), ligation amplification (or ligase chain reaction, LCR), strand displacement amplification, nucleic acid sequence-based amplification, and amplification methods based on the use of Q-beta replicase. 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
These methods are well known and widely practiced in the art.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f (emphasis added)).)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Claim four cites to claim one and includes eight different types of detection methods, each of which is a routine, conventional, and well-known approach to genetic detection. (\u8242\'3f297 Patent, col. 99, l. 37\u8211\'3f43 (listing the following eight detection methods: \u8220\'3fa) allele specific hybridization; b) size analysis; c) sequencing; d) hybridization; e) 5\rquote  nuclease digestion; f) single-stranded conformation polymorphism; g) primer specific extension; and/or h) oligonucleotide ligation assay\u8221\'3f).) Two of the eight techniques involve hybridization, a widely utilized genetic technique. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_764&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_764" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
BRCA,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 774 F.3d at 764\u8211\'3f65
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (noting that the patent claims at issue involved hybridization and concluding that the techniques employed were clearly \u8220\'3fwell-understood, routine, and conventional\u8221\'3f); 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
see also
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, col. 4, l. 4\u8211\'3f13 (\u8220\'3fIn one embodiment of the present invention, the method also involves contacting the sample with at least one oligonucleotide probe to form a hybridized nucleic acid and amplifying the hybridized nucleic acid.... These methods are well known and widely practiced in the art.\u8221\'3f))
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00552035751272_ID0EB1BI_80}{\*\bkmkend co_fnRef_B00552035751272_ID0EB1BI_80}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00552035751272_80" }{\fldrslt 
{\super \b0 \cf28 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
5
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_846_80}{\*\bkmkend co_pp_sp_7903_846_80}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*846
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The same is true of size analysis, (First Walters Decl., Ex. C at 6 (discussing a type of size analysis in a technical article from 1989 on the amplification of a specific genetic locus)); sequencing, (\u8242\'3f297 Patent, col. 27, l. 8\u8211\'3f10 (\u8220\'3fDetection of point mutations may be accomplished by 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=mproc&entityId=Ic3f3a09c475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
molecular cloning
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 of the DNM1 allele(s) and sequencing the allele(s) using techniques well known in the art.\u8221\'3f)); 5\u8242\'3f nuclease digestion, (First Walters Decl., Ex. D at 2 (describing, in a 1999 article, a 5\u8242\'3f nuclease assay as an \u8220\'3fattractive\u8221\'3f option for screening for polymorphisms)); single-stranded conformation polymorphism, (\u8242\'3f297 Patent, col. 27, l. 15\u8211\'3f17 (\u8220\'3fThere are six well known methods for a more complete, yet still indirect, test for confirming the presence of a mutant allele: 1) single stranded conformation analysis....\u8221\'3f)); primer specific extension, (First Walters Decl., Ex. F at 5 (discussing, in a 1990 article, primer specific extension as a tool for detecting a nucleotide at a variable site of target DNA)); and oligonucleotide ligation assay, (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Ex. G at 6 (\u8220\'3fBoth ligation and binding of the ... oligonucleotides are efficient and rapid steps that should permit quantitative detection of target molecules.\u8221\'3f).)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Claim five references claim four, and clarifies that the detecting step \u8220\'3fis by size analysis, and the size analysis is preceded by a restriction enzyme digestion.\u8221\'3f (\u8242\'3f297 Patent, col. 99, l. 42\u8211\'3f45.) A 1986 article provided by PPG shows that this technique was also well-known at the time the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 was issued. (First Walters Decl., Ex. H at 34 (\u8220\'3fMapping [of restriction sites surrounding a polymorphic site] was performed by standard procedures with single and double 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
restriction enzyme digests.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f (emphasis added)).) Similarly, claim six, which references claim one and has a detection step that involves \u8220\'3fhybridization of the nucleic acid sample from the dog to at least one oligonucleotide probe specific for the dynamin 1 (G767T) allele\u8221\'3f and immobilization \u8220\'3fon a solid surface,\u8221\'3f (\u8242\'3f297 Patent, col. 100, l. 23\u8211\'3f27), involves well-known probing and detection techniques. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 30, l. 26\u8211\'3f28 (\u8220\'3fThe DNA (or nucleic acid) sample may be contacted with the oligonucleotide probe in any suitable manner known to those skilled in the art.\u8221\'3f).)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Claims seven offers nothing beyond claim one; it simply references the detection method in the first claim and specifies that the dog in question is one of four canine breeds. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 100, l. 27\u8211\'3f30.) Finally, claim eight, the only other independent claim, aside from claim one, which references no other claim, suffers from the same infirmities as claim one. Like claim one, claim eight specifies as its purpose determining \u8220\'3fwhether a dog has or is predisposed to developing\u8221\'3f EIC. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 100, l. 31\u8211\'3f33.) Then the claim essentially provides the same steps as in claim one: detection and identification. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 l. 37\u8211\'3f41.) The only difference is that the claim also includes two added steps: transporting a sample from the dog to a laboratory prior to detection and identification and, afterward, providing the results of detection and identification. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 l. 33\u8211\'3f36, 42\u8211\'3f45.) Claim eight contains no patent-eligible inventive concept. Moreover, considering each claim, and the steps involved in each, in \u8220\'3fordered combination\u8221\'3f does not change the analysis; no set of steps in any of the claims, viewed as a whole, provides an inventive concept that renders the claims patent eligible. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_1298&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1298" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 132 S.Ct. at 1298
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The broad principles in 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Alice Corp.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 also support the Court\rquote s conclusion. 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_847_80}{\*\bkmkend co_pp_sp_7903_847_80}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*847
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Like the patent claims at issue in 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 the key claims at issue in the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8212\'3fclaims one and eight\u8212\'3finvolve generalized steps that essentially tell experts about the natural law; the claims simply tell someone treating a canine to detect whether the natural law\u8212\'3fthe specific allele tied to EIC\u8212\'3fexists or is implicated in the dog being treated. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_1297&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1297" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 132 S.Ct. at 1297\u8211\'3f98
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (concluding that the patent\rquote s three steps (labeled the administering, determining, and wherein steps) were insufficient to transform the claim into a patent-eligible one, and noting that case law supports \u8220\'3fthe view that simply appending conventional steps, specified at a high level of generality, to laws of nature, natural phenomena, and abstract ideas cannot make those laws ... patentable\u8221\'3f); 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
see also 
}
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2360&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2360" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Alice Corp.,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 134 S.Ct. at 2360
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (rejecting as patent ineligible a method claim that involved an \u8220\'3fabstract idea implemented on a generic computer\u8221\'3f and noting that \u8220\'3fthe function performed by the computer at each step of the process [was] purely conventional\u8221\'3f (internal quotation marks and alterations omitted)).
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Canine EIC contrasts this case with 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 arguing that certain claims in the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8212\'3fspecifically claims two through six\u8212\'3finvolve more detailed processes than the steps in 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 which operated at a \u8220\'3fhigh level of generality,\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_1300&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1300" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 132 S.Ct. at 1300
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The decisions in 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
BRCA, Ariosa,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Genetic Technologies Ltd.,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 however, show that this Court\rquote s decision to find that all eight claims in the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 are patent-ineligible best comports with the Supreme Court\rquote s precedent. In 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
BRCA,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 for example, the claims at issue involved detailed and specific hybridization and amplification techniques for comparing a person\rquote s genes with the wild-type and identifying differences. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_761&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_761" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
BRCA,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 774 F.3d at 761\u8211\'3f72
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The court concluded that the claims involved an abstract idea, versus a natural law, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_762&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_762" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 762
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, but the analysis at 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 step two is the same for natural laws and abstract ideas, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_764&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_764" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 764\u8211\'3f65
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Alice Corp.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 in its 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 step two analysis). The 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
BRCA
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 court acknowledged that the claims offered more than just the patent-ineligible abstract idea: it noted that the claims included complex hybridization and amplification processes. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_764&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_764" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 764
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. But it concluded nonetheless that these techniques provided no new inventive concept. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Instead, just like the detection techniques outlined in all eight claims in this case, the 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
BRCA
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 court found that the claims at issue did \u8220\'3fnothing more than spell out what practitioners already knew\u8212\'3fhow to compare gene sequences using routine, ordinary techniques.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00662035751272_ID0EJTCI_80}{\*\bkmkend co_fnRef_B00662035751272_ID0EJTCI_80}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00662035751272_80" }{\fldrslt 
{\super \b0 \cf28 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
6
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The court in 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Ariosa
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 reached the same conclusion about patents that provided detailed steps for detecting cffDNA from maternal serums or plasma. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2031885892&pubNum=0007903&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_7903_941&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_7903_941" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Ariosa Diagnostics, Inc.,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 19 F.Supp.3d at 941\u8211\'3f42, 949\u8211\'3f50
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
see also 
}
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2034293397&pubNum=0000999&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Genetic Techs. Ltd.,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 2014 WL 4379587, at *2, *11\u8211\'3f*14
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Even if the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is not saved by the detailed processes recounted in all eight claims, Canine 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibb57a688475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
EIC
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 also notes that the patent is sufficiently limited and narrow in that it only patents the connection between one mutation and one disease, without controlling the ties between that mutation and other diseases, or even patenting any detection of a dog that is heterozygous, as opposed to homozygous, for the 767T allele. In other words, the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is more akin to claim 21 of the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1998348225&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=Ibce1a8d0722911d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
441 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 in 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
BRCA,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 which was limited to particular genetic alterations tied to specific 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Iaf34f5c3475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
cancers
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_765&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_765" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
774 F.3d at 765
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. And the \u8242\'3f 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_848_80}{\*\bkmkend co_pp_sp_7903_848_80}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*848
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is not so broad as to \u8220\'3fpreempt\u8221\'3f entirely the use of the natural law at issue. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_1294&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1294" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 132 S.Ct. at 1294
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
see also 
}
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2031885892&pubNum=0007903&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_7903_953&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_7903_953" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Ariosa,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 19 F.Supp.3d at 953
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. But analogizing to the complicated relationship between mutations in the BRCA genes and 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Iaf34f5c3475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
cancer
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8212\'3fa complex and multi-faceted disease with many iterations\u8212\'3fis only so helpful in analyzing a simpler case. The \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 identifies the relationship between a specific mutation and a unique disease in dogs. By delineating a long list of conventional, routine, and well-known processes for identifying the mutation associated with the disease, the patent seeks to tie up and control any detection and research related to that biomarker and EIC. Indeed, the patent\rquote s language is written in broad strokes, making clear that its purpose is to control that connection. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See, e.g.,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, cols. 1, l. 57\u8211\'3f60; 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 2, l. 49\u8211\'3f51.) Canine EIC provides no evidence that other biomarkers may be associated with EIC, or that the biomarker at issue may be associated with other iterations of EIC or similar diseases. It has not shown that the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is doing nothing more than narrowly wading into a deep ocean of research and innovation around dogs, genetics, and EIC. Instead, the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 broadly seeks to control all the ties between the 767T allele and EIC, which renders it ineligible for patent protection.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00772035751272_ID0ET2CI_80}{\*\bkmkend co_fnRef_B00772035751272_ID0ET2CI_80}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00772035751272_80" }{\fldrslt 
{\super \b0 \cf28 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
7
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Finally, to the extent Canine EIC argues that the processes in its \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 are non-natural, or that the novelty or lack thereof of the processes and methods are not at issue, it ignores the clear guidance from the Supreme Court and the Federal Circuit in 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and its progeny on how to analyze 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 cases. The question is not whether any aspect of the patent involves non-natural processes; it is what the patent is directed to and\u8212\'3fif the patent is directed to a patent-ineligible concept\u8212\'3fwhether the non-natural processes provide an additional inventive concept of enough heft to make the patent valid. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_1296&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1296" }{\fldrslt 
{\b0 \cf28 \f2 \i1 \fs20 
{\b0 \cf28 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo,
}
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 132 S.Ct. at 1296\u8211\'3f98
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. As a result, the novelty of the processes included in the patent\u8212\'3fwhether they are truly new and innovative, or whether they are routine, well-known, and conventional\u8212\'3fis absolutely central to the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf21 \f2 \i0 \fs20 \chcbpat29 
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf28 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 analysis. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Here, the Court concludes that no inventive concept saves the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027695983&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=I5fabfda09f5111e1bb9ae0ab30618686&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
297 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 from its focus on a patent-ineligible natural law. Because all that it adds to the natural law are well-known genetic detection methods, the Court finds the patent\rquote s eight claims to be invalid and will grant PPG\rquote s motion for partial summary judgment.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269d78b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269d78b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ifa9269d78b0f11ea80afece799150}{\*\bkmkend co_anchor_Ifa9269d78b0f11ea80afece799150}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb600 
ORDER
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Based on the foregoing, and all the files, records, and proceedings herein, 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
IT IS HEREBY ORDERED
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 that Genetic Veterinary 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_849_80}{\*\bkmkend co_pp_sp_7903_849_80}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*849
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Sciences, Inc.\rquote s Motion for Partial Summary Judgment [Docket No. 42] is 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
GRANTED.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf22 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_allCitations_80}{\*\bkmkend co_allCitations_80}
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
All Citations
\par 
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101 F.Supp.3d 833
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
}
}
{\b0 \cf1 \f3 \ri0 \i0 \ql \fs24 \li0 \par}\sect\sbknone\pgncont\cols1{\ids0 {
{\trowd \ltrrow \trleft0 
\clpadl200 \clpadfl3 \clbrdrt \clbrdrl \trql \clwWidth10080 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \ql \fs20 \li0 
{\b0 \cf1 \f3 \i0 \fs20 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Footnotes
\par 
}
}
}
}\b0 \cf1 \f3 \ri0 \ul0 \strike0 \i0 \ql \li0 \fs20 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f3 \i0 \fs24 
{\*\bkmkstart co_footnote_B00112035751272_80}{\*\bkmkend co_footnote_B00112035751272_80}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00112035751272_ID0EZIAG_80" }{\fldrslt 
{\super \b0 \cf28 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
1
}\super \b0 \cf28 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f3 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Dr. Patterson\rquote s research indicated that Canine EIC is an \u8220\'3fautosomal recessive condition.\u8221\'3f (Patterson Decl. \u182\'3f 7.) The gene is on an autosome, chromosome 9: a non-sex chromosome. (
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
) EIC appears only if the dog has received two copies of the gene, one from each parent. (
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
) When a dog has two copies of the gene, it is called homozygous. (
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 \u182\'3f 8.) If a dog has only one copy of the gene, it is considered a carrier. (
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 \u182\'3f 9.)
\par 
}
}
}
}
}\b0 \cf1 \f3 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f3 \i0 \fs24 
{\*\bkmkstart co_footnote_B00222035751272_80}{\*\bkmkend co_footnote_B00222035751272_80}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00222035751272_ID0EY6BG_80" }{\fldrslt 
{\super \b0 \cf28 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
2
}\super \b0 \cf28 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f3 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
The 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 two-step analysis is essentially the same, whether the patent is directed at a law of nature or an abstract idea. 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See 
}
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2357&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2357" }{\fldrslt 
{\b0 \cf28 \f3 \i1 \fs18 
{\b0 \cf28 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Alice Corp.,
}
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 134 S.Ct. at 2357
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (applying the 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Mayo
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 analysis, which involved a patent directed at a law of nature, to a patent directed at an abstract idea).
\par 
}
}
}
}
}\b0 \cf1 \f3 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f3 \i0 \fs24 
{\*\bkmkstart co_footnote_B00332035751272_80}{\*\bkmkend co_footnote_B00332035751272_80}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00332035751272_ID0EF4AI_80" }{\fldrslt 
{\super \b0 \cf28 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
3
}\super \b0 \cf28 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f3 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Canine EIC also briefly argues that this Court should not render a decision on patent ineligibility before engaging in a formal claim construction or allowing for discovery. However, the parties do not present any factual disputes, or competing claim constructions, that warrant a delay. As other courts have noted, a Court may proceed with a 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf21 \f3 \i0 \fs18 \chcbpat29 
{\b1 \cf21 \f3 \i0 \fs18 \chcbpat29 
{\b1 \cf21 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Section
}
}
}
{\b0 \cf28 \f3 \i0 \fs18 \chcbpat2 
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b1 \cf21 \f3 \i0 \fs18 \chcbpat29 
{\b1 \cf21 \f3 \i0 \fs18 \chcbpat29 
{\b1 \cf21 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
101
}
}
}
{\b0 \cf28 \f3 \i0 \fs18 \chcbpat2 
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 analysis at the summary judgment stage, even if there has not been factual discovery or formal claim construction. 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See, e.g., 
}
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2032785610&pubNum=0006538&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_6538_991&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_6538_991" }{\fldrslt 
{\b0 \cf28 \f3 \i1 \fs18 
{\b0 \cf28 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Cyberfone Sys., LLC v. CNN Interactive Grp., Inc.,
}
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 558 Fed.Appx. 988, 991 n. 1 (Fed.Cir.2014)
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (\u8220\'3f[The plaintiff] argues that claim construction must precede the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf21 \f3 \i0 \fs18 \chcbpat29 
{\b1 \cf21 \f3 \i0 \fs18 \chcbpat29 
{\b1 \cf21 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u167\'3f
}
}
}
{\b0 \cf28 \f3 \i0 \fs18 \chcbpat2 
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b1 \cf21 \f3 \i0 \fs18 \chcbpat29 
{\b1 \cf21 \f3 \i0 \fs18 \chcbpat29 
{\b1 \cf21 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
101
}
}
}
{\b0 \cf28 \f3 \i0 \fs18 \chcbpat2 
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 analysis, but does not explain which terms require construction or how the analysis would change.... There is no requirement that the district court engage in claim construction before deciding 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf21 \f3 \i0 \fs18 \chcbpat29 
{\b1 \cf21 \f3 \i0 \fs18 \chcbpat29 
{\b1 \cf21 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u167\'3f
}
}
}
{\b0 \cf28 \f3 \i0 \fs18 \chcbpat2 
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b1 \cf21 \f3 \i0 \fs18 \chcbpat29 
{\b1 \cf21 \f3 \i0 \fs18 \chcbpat29 
{\b1 \cf21 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
101
}
}
}
{\b0 \cf28 \f3 \i0 \fs18 \chcbpat2 
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 eligibility.\u8221\'3f); 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2034293397&pubNum=0000999&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f3 \i1 \fs18 
{\b0 \cf28 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Genetic Techs. Ltd.,
}
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 2014 WL 4379587, at *5\u8211\'3f*6
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
.
\par 
}
}
}
}
}\b0 \cf1 \f3 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f3 \i0 \fs24 
{\*\bkmkstart co_footnote_B00442035751272_80}{\*\bkmkend co_footnote_B00442035751272_80}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00442035751272_ID0E4JBI_80" }{\fldrslt 
{\super \b0 \cf28 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
4
}\super \b0 \cf28 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f3 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
To the extent that Canine EIC attempts to distinguish this case from some of those cited by PPG because those cases involve patents that relate to human\u8212\'3fand not canine\u8212\'3ftreatments, testing, or genetics, the Court finds no authority that gives any weight to this distinction. The question of whether a test, or set of tests, for discovering a genetic mutation is protected by the patent laws is analyzed the same way, irrespective of whether that test is used on humans or dogs.
\par 
}
}
}
}
}\b0 \cf1 \f3 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f3 \i0 \fs24 
{\*\bkmkstart co_footnote_B00552035751272_80}{\*\bkmkend co_footnote_B00552035751272_80}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00552035751272_ID0EB1BI_80" }{\fldrslt 
{\super \b0 \cf28 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
5
}\super \b0 \cf28 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f3 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
In a decision by the Federal Circuit that was later affirmed in part and reversed in part by the Supreme Court in 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Myriad,
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Judge Bryson concurred in part and dissented in part regarding Myriad\rquote s BRCA patents. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2028417793&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_1348&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1348" }{\fldrslt 
{\b0 \cf28 \f3 \i1 \fs18 
{\b0 \cf28 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Ass\rquote n for Molecular Pathology v. U.S. Patent & Trademark Office,
}
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 689 F.3d 1303, 1348\u8211\'3f49 (Fed.Cir.2012)
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (Bryson, J., concurring in part and dissenting in part), 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
aff\rquote d in part, rev\rquote d in part sub nom. 
}
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2120&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2120" }{\fldrslt 
{\b0 \cf28 \f3 \i1 \fs18 
{\b0 \cf28 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Myriad,
}
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 133 S.Ct. at 2120
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. In discussing Myriad\rquote s attempt to patent a natural law, Judge Bryson noted that while the company could not patent a law of nature, it could \u8220\'3fpatent 
}
{\b1 \cf1 \f3 \i0 \fs18 
{\b1 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
applications
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 of its discovery.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2028417793&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_1349&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1349" }{\fldrslt 
{\b0 \cf28 \f3 \i1 \fs18 
{\b0 \cf28 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 at 1349
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (emphasis added). Judge Bryson elaborated: \u8220\'3fAs the first party with knowledge of the [BRCA] sequences, Myriad was in an excellent position to claim applications of that knowledge. Many of its unchallenged claims are limited to such applications.\u8221\'3f 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Judge Bryson used as an example of one of these valid applications of natural law claim 21 of the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1998348225&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=Ibce1a8d0722911d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
441 patent
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, which involved the detection of a germlike alteration in a BRCA1 gene by hybridizing a BRCA1 gene probe. 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (citing 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1998348225&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=Ibce1a8d0722911d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
U.S. Patent No. 5753441 (filed May 19, 1998)
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
). In 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Myriad,
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 the Supreme Court cited favorably Judge Bryson\rquote s statement regarding Myriad\rquote s ability to claim application of that knowledge, since it was the company that discovered the BRCA1 and BRCA2 sequences. 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See 
}
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_708_2120&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2120" }{\fldrslt 
{\b0 \cf28 \f3 \i1 \fs18 
{\b0 \cf28 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Myriad,
}
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 133 S.Ct. at 2120
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
.
\par 
}
}
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Some courts have discussed whether Judge Bryson\rquote s language\u8212\'3fspecifically his use of claim 21 of the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1998348225&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=Ibce1a8d0722911d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
441 patent
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 as an example, and the Supreme Court\rquote s implicit adoption of some of his language, implies that using hybridization techniques is a specific application of a natural law that is patent eligible. 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See 
}
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2031885892&pubNum=0007903&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_7903_952&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_7903_952" }{\fldrslt 
{\b0 \cf28 \f3 \i1 \fs18 
{\b0 \cf28 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Ariosa Diagnostics, Inc.,
}
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 19 F.Supp.3d at 952 n. 8
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. The 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Ariosa
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 court rejected that implication, noting that the parties in its case had not shown that hybridization was conventional at the time of the patent that Judge Bryson was discussing. 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 In other words, the 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Ariosa
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 court declined to read too much into Judge Bryson\rquote s language, because it was not clear whether hybridization was conventional or new at the time and, as a result, it was unknown what exactly had led Judge Bryson to read claim 21 and its hybridization method as patent-eligible.
\par 
}
}
}
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
This Court concludes that hybridization is routine and conventional, given the evidence presented by PPG. And the Court does not read Judge Bryson\rquote s language as requiring it to uphold the validity of a patent that uses a hybridization method. Indeed, since 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Ariosa,
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 the Federal Circuit in 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
BRCA
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 has clarified that\u8212\'3fassuming Judge Bryson was correct about claim 21 of the \u8242\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1998348225&pubNum=0004074&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=PA&docFamilyGuid=Ibce1a8d0722911d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
441 patent
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u8212\'3fwhat made that claim valid was not its use of hybridization, but its narrowness. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_765&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_765" }{\fldrslt 
{\b0 \cf28 \f3 \i1 \fs18 
{\b0 \cf28 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
BRCA,
}
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 774 F.3d at 765
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (\u8220\'3fClaim 21 claims a method of detecting alterations in which the alterations being detected are expressly identified in the specification by tables 11 and 12.... Thus, the detection in claim 21 is limited to the particular mutations the inventors discovered: detecting ten specific mutations from the wild-type....\u8221\'3f) The Court will therefore not read more into Judge Bryson\rquote s language than the Federal Circuit did. The Court will address separately below the argument that Judge Bryson\rquote s language, and the language in 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
BRCA,
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 show that this case involves a narrower application of a natural law\u8212\'3fwhich is therefore patent eligible\u8212\'3fthan the broad patents at issue in 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Ariosa
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 and 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
BRCA.
\par 
}
}
}
}
}
}
}\b0 \cf1 \f3 \ri0 \ul0 \strike0 \i1 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f3 \i0 \fs24 
{\*\bkmkstart co_footnote_B00662035751272_80}{\*\bkmkend co_footnote_B00662035751272_80}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00662035751272_ID0EJTCI_80" }{\fldrslt 
{\super \b0 \cf28 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
6
}\super \b0 \cf28 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f3 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
To the extent Canine EIC relies on 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2034937126&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_1249&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1249" }{\fldrslt 
{\b0 \cf28 \f3 \i1 \fs18 
{\b0 \cf28 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
DDR Holdings, LLC v. Hotels.com, L.P.,
}
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 773 F.3d 1245, 1249, 1258\u8211\'3f59 (Fed.Cir.2014)
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, which involves an online marketing patent, the Court concludes that 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
BRCA
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 is more relevant and on point, since it involves a genetic patent similar to the one at issue in this case.
\par 
}
}
}
}
}\b0 \cf1 \f3 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \lastrow \trleft0 
\clbrdrb \clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrb \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f3 \i0 \fs24 
{\*\bkmkstart co_footnote_B00772035751272_80}{\*\bkmkend co_footnote_B00772035751272_80}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00772035751272_ID0ET2CI_80" }{\fldrslt 
{\super \b0 \cf28 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
7
}\super \b0 \cf28 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f3 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Canine EIC also relies on the decision in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2032876990&pubNum=0007903&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_7903_928&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_7903_928" }{\fldrslt 
{\b0 \cf28 \f3 \i1 \fs18 
{\b0 \cf28 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Genetic Technologies, Ltd. v. Agilent Technologies, Inc.
}
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (
}
{\b0 \cf28 \f3 \i1 \fs18 
{\b0 \cf28 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Agilent
}
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 ), 24 F.Supp.3d 922, 928\u8211\'3f29 (N.D.Cal.2014)
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, which concluded that a patent that covered \u8220\'3fthe correlation between [genomic] variations in non-coding and coding DNA regions\u8221\'3f was an unpatentable law of nature, but then found that it was eligible for patent protection because it offered an additional inventive concept. This case is distinguishable in large part because the court in 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Agilent
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 was considering a motion to dismiss and was restricted to the complaint at issue. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2032876990&pubNum=0007903&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_7903_925&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_7903_925" }{\fldrslt 
{\b0 \cf28 \f3 \i1 \fs18 
{\b0 \cf28 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 at 925, 933
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. More importantly, the court in 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Agilent
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 relied on a rigid application of the Federal Circuit\rquote s decision in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030821372&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f3 \i1 \fs18 
{\b0 \cf28 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Ultramercial, Inc. v. Hulu, LLC,
}
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 722 F.3d 1335 (Fed.Cir.2013)
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, a case the Supreme Court has since vacated, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2031350142&pubNum=0000708&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf28 \f3 \i1 \fs18 
{\b0 \cf28 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
WildTangent, Inc. v. Ultramercial, LLC,
}
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 \u8211\'3f\u8211\'3f\u8211\'3f U.S. \u8211\'3f\u8211\'3f\u8211\'3f\u8211\'3f, 134 S.Ct. 2870, 189 L.Ed.2d 828 (2014)
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. Indeed, on remand the Federal Circuit did not follow the same reasoning process as in its vacated 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Ultramercial
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 decision; specifically, it did not so rigidly apply the four factors Canine EIC applies in its brief. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2034793628&pubNum=0000506&originatingDoc=Idb127474daab11e4a795ac035416da91&refType=RP&fi=co_pp_sp_506_715&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_715" }{\fldrslt 
{\b0 \cf28 \f3 \i1 \fs18 
{\b0 \cf28 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Ultramercial, Inc. v. Hulu, LLC,
}
}
{\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 772 F.3d 709, 715\u8211\'3f16 (2014)
}\b0 \cf28 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. As a result, the Court finds that cases like 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
BRCA
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 and 
}
{\b0 \cf1 \f3 \i1 \fs18 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Ariosa
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 are more relevant to this case.
\par 
}
}
}
}
}\b0 \cf1 \f3 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }}\par 
}
{\b0 \cf1 \f2 \ri0 \par}\sect\sbknone\pgncont\cols2{\ids0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
}
}
{\b0 \cf1 \f3 \ri0 \i0 \ql \fs24 \li0 \par}\sect\sbknone\pgncont\cols1{\ids0 {
{\trowd \lastrow \trleft0 
\clpadt24 \clpadft3 \clpadl100 \clpadfl3 \clpadr24 \clpadfr3 \clbrdrt \brdrcf24 \brdrw10 \brdrs \clbrdrb \clbrdrl \trql \clvertalt \clwWidth4320 \cellx4320 
\clpadt29 \clpadft3 \clpadl100 \clpadfl3 \clpadr29 \clpadfr3 \clbrdrt \brdrcf24 \brdrw10 \brdrs \clbrdrb \clbrdrr \trql \clvertalt \clwWidth5760 \cellx10080 
\intbl 
{\ri24 \li24 
{\b1 \cf24 \f3 \ri24 \i0 \ql \fs16 \li24 
{\b1 \cf24 \f3 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
End of Document
\par 
}
}
}\b1 \cf24 \f3 \ri24 \ul0 \strike0 \i0 \ql \li24 \fs16 \sa0 \sb0 \intbl \cell \intbl 
{\ri29 \li29 
{\qr \b0 \cf24 \f3 \ri29 \i0 \fs19 \li29 
{\b0 \cf24 \f3 \ul0 \strike0 \i0 \fs19 \sa0 \sb0 
\u169\'3f 2021 Thomson Reuters. No claim to original U.S. Government Works.
\par 
}
}
}\qr \b0 \cf24 \f3 \ri29 \ul0 \strike0 \i0 \li29 \fs19 \sa0 \sb0 \intbl \cell \row }}\par 
}
{\b0 \cf1 \f2 \ri0 \par}\sect\sbknone\pgncont\cols2{\ids0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
}
}\sect }